These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 29431737)

  • 21. MUC1 aptamer-targeted DNA micelles for dual tumor therapy using doxorubicin and KLA peptide.
    Charbgoo F; Alibolandi M; Taghdisi SM; Abnous K; Soltani F; Ramezani M
    Nanomedicine; 2018 Apr; 14(3):685-697. PubMed ID: 29317345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery.
    Guo J; Gao X; Su L; Xia H; Gu G; Pang Z; Jiang X; Yao L; Chen J; Chen H
    Biomaterials; 2011 Nov; 32(31):8010-20. PubMed ID: 21788069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Engineering a Second-Order DNA Logic-Gated Nanorobot to Sense and Release on Live Cell Membranes for Multiplexed Diagnosis and Synergistic Therapy.
    Wang D; Li S; Zhao Z; Zhang X; Tan W
    Angew Chem Int Ed Engl; 2021 Jul; 60(29):15816-15820. PubMed ID: 33908144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. G-quartet oligonucleotide mediated delivery of proteins into photoreceptors and retinal pigment epithelium via intravitreal injection.
    Leaderer D; Cashman SM; Kumar-Singh R
    Exp Eye Res; 2016 Apr; 145():380-392. PubMed ID: 26923800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor targeting with a (99m)Tc-labeled AS1411 aptamer in prostate tumor cells.
    Noaparast Z; Hosseinimehr SJ; Piramoon M; Abedi SM
    J Drug Target; 2015; 23(6):497-505. PubMed ID: 25673264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AS1411-Induced Growth Inhibition of Glioma Cells by Up-Regulation of p53 and Down-Regulation of Bcl-2 and Akt1 via Nucleolin.
    Cheng Y; Zhao G; Zhang S; Nigim F; Zhou G; Yu Z; Song Y; Chen Y; Li Y
    PLoS One; 2016; 11(12):e0167094. PubMed ID: 27907160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chimeric nucleolin aptamer with survivin DNAzyme for cancer cell targeted delivery.
    Subramanian N; Kanwar JR; Akilandeswari B; Kanwar RK; Khetan V; Krishnakumar S
    Chem Commun (Camb); 2015 Apr; 51(32):6940-3. PubMed ID: 25797393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An F
    Yang Q; Zhou X; Lou B; Zheng N; Chen J; Yang G
    Acta Biomater; 2024 Apr; 179():207-219. PubMed ID: 38513724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced growth inhibition of prostate cancer in vitro and in vivo by a recombinant adenovirus-mediated dual-aptamer modified drug delivery system.
    Jing P; Cao S; Xiao S; Zhang X; Ke S; Ke F; Yu X; Wang L; Wang S; Luo Y; Zhong Z
    Cancer Lett; 2016 Dec; 383(2):230-242. PubMed ID: 27721020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aptamer-nanoparticle bioconjugates enhance intracellular delivery of vinorelbine to breast cancer cells.
    Zhou W; Zhou Y; Wu J; Liu Z; Zhao H; Liu J; Ding J
    J Drug Target; 2014 Jan; 22(1):57-66. PubMed ID: 24156476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Precise glioblastoma targeting by AS1411 aptamer-functionalized poly (l-γ-glutamylglutamine)-paclitaxel nanoconjugates.
    Luo Z; Yan Z; Jin K; Pang Q; Jiang T; Lu H; Liu X; Pang Z; Yu L; Jiang X
    J Colloid Interface Sci; 2017 Mar; 490():783-796. PubMed ID: 27988470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Micellar Thrombin-Binding Aptamers: Reversible Nanoscale Anticoagulants.
    Roloff A; Carlini AS; Callmann CE; Gianneschi NC
    J Am Chem Soc; 2017 Nov; 139(46):16442-16445. PubMed ID: 29135251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Tubular DNA Nanodevice as a siRNA/Chemo-Drug Co-delivery Vehicle for Combined Cancer Therapy.
    Wang Z; Song L; Liu Q; Tian R; Shang Y; Liu F; Liu S; Zhao S; Han Z; Sun J; Jiang Q; Ding B
    Angew Chem Int Ed Engl; 2021 Feb; 60(5):2594-2598. PubMed ID: 33089613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Smart bomb AS1411 aptamer-functionalized/PAMAM dendrimer nanocarriers for targeted drug delivery in the treatment of gastric cancer.
    Barzegar Behrooz A; Nabavizadeh F; Adiban J; Shafiee Ardestani M; Vahabpour R; Aghasadeghi MR; Sohanaki H
    Clin Exp Pharmacol Physiol; 2017 Jan; 44(1):41-51. PubMed ID: 27626786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aptamer-based tumor-targeted drug delivery for photodynamic therapy.
    Shieh YA; Yang SJ; Wei MF; Shieh MJ
    ACS Nano; 2010 Mar; 4(3):1433-42. PubMed ID: 20166743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Micro/Nanorobot: A Promising Targeted Drug Delivery System.
    Hu M; Ge X; Chen X; Mao W; Qian X; Yuan WE
    Pharmaceutics; 2020 Jul; 12(7):. PubMed ID: 32679772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of in vivo tumor angiogenesis and growth via systemic delivery of an angiopoietin 2-specific RNA aptamer.
    Sarraf-Yazdi S; Mi J; Moeller BJ; Niu X; White RR; Kontos CD; Sullenger BA; Dewhirst MW; Clary BM
    J Surg Res; 2008 May; 146(1):16-23. PubMed ID: 17950331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ultrasound-mediated nanobubble destruction (UMND) facilitates the delivery of A10-3.2 aptamer targeted and siRNA-loaded cationic nanobubbles for therapy of prostate cancer.
    Wu M; Zhao H; Guo L; Wang Y; Song J; Zhao X; Li C; Hao L; Wang D; Tang J
    Drug Deliv; 2018 Nov; 25(1):226-240. PubMed ID: 29313393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nucleolin overexpression in breast cancer cell sub-populations with different stem-like phenotype enables targeted intracellular delivery of synergistic drug combination.
    Fonseca NA; Rodrigues AS; Rodrigues-Santos P; Alves V; Gregório AC; Valério-Fernandes Â; Gomes-da-Silva LC; Rosa MS; Moura V; Ramalho-Santos J; Simões S; Moreira JN
    Biomaterials; 2015 Nov; 69():76-88. PubMed ID: 26283155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Encoding Manipulation of DNA-Nanoparticle Assembled Nanorobot Using Independently Charged Array Nanopores.
    Si W; Zhu Z; Wu G; Zhang Y; Chen Y; Sha J
    Small Methods; 2022 Aug; 6(8):e2200318. PubMed ID: 35656741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.